Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies

After being stagnant for decades, there has finally been a paradigm shift in the treatment of cancer with the emergence and application of immune checkpoint inhibitors (ICIs). The most extensively utilized ICIs are targeting the pathways involving programmed death-1 (PD-1) and cytotoxic T-lymphocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenwen, Lei, Caining, Song, Shaoming, Jing, Wutang, Jin, Chuanwei, Gong, Shiyi, Tian, Hongwei, Guo, Tiankang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565029/
https://www.ncbi.nlm.nih.gov/pubmed/34727927
http://dx.doi.org/10.1186/s12935-021-02299-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565029/
https://www.ncbi.nlm.nih.gov/pubmed/34727927
http://dx.doi.org/10.1186/s12935-021-02299-8

Ejemplares similares